Status:
COMPLETED
Ultrafiltration on Coagulation Function in Cardiac Surgery
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Cardiac Valve Disease
Eligibility:
All Genders
19-75 years
Phase:
NA
Brief Summary
To determine the effect of modified ultrafiltration, which is usually employed for reducing free water at the end of cardiopulmonary bypass (CPB), on coagulation profile in patients undergoing cardiac...
Eligibility Criteria
Inclusion
- patients undergoing elective cardiac surgery with cardiopulmonary bypass (CPB)
- maximal clot formation (MCF) in ROTEM-EXTEM is reduced (\< 50.5 mm before applying ultrafiltration)
Exclusion
- transfusion of packed RBC\> 3 units during CPB
- total ultrafiltration volume \< 250 ml
- hyperfibrinolysis (lysis% \> 10%) before applying ultrafiltration
Key Trial Info
Start Date :
January 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04031144
Start Date
January 30 2020
End Date
October 30 2023
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, Seoul, South Korea, 05030